Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Dexmedetomidine and fentanyl added to lidocaine for infraclavicular brachial plexus block
IRCT20131108015322N7Phase 3Completed
- Sponsor
- Shahid Beheshti University of Medical Sciences
- Start
- Oct 2022
- Modality
- Small Molecules, Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules
- Countries
- 1
01
Overview
Phase 3, randomised trial of dexmedetomidine, fentanyl and lidocaine in postoperative pain (4 arms), sponsored by Shahid Beheshti University of Medical Sciences. Primary endpoints: Onset of sensory block, Duration of sensory block and 3 more. Started Oct 2022; status: completed.
02
Drugs
dexmedetomidinefentanyllidocaine
03
Conditions
postoperative pain
Beyond the preview
Go deeper on IRCT20131108015322N7.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20131108015322N7.